Table 2.
Discovery | North America | ||||||||||
rs9652490 | Controls | PD | ET | ||||||||
Genotype | n | freq | n | freq | P-value | OR (95%CI) | n | freq | P-value | OR (95%CI) | |
A/A | 229 | 0.574 | 238 | 0.579 | 0.0117 | 2.1 (1.1–3.8) | 215 | 0.609 | 0.0145 | 2.2 (1.1–4.2) | |
A/G | 137 | 0.343 | 156 | 0.380 | 124 | 0.351 | |||||
G/G | 33 | 0.083 | 17 | 0.041 | 14 | 0.040 | |||||
Replication | Norway | ||||||||||
rs9652490 | Controls | PD | |||||||||
Genotype | n | freq | n | freq | P-value | OR (95%CI) | |||||
A/A | 332 | 0.575 | 318 | 0.547 | 0.0078 | 1.7 (1.0–2.7) | |||||
A/G | 200 | 0.347 | 235 | 0.404 | |||||||
G/G | 45 | 0.078 | 28 | 0.048 | |||||||
Meta-analysis | |||||||||||
rs9652490 | Controls | Combined PD | Combined PD and ET | ||||||||
Genotype | n | freq | n | freq | P-value | OR (95%CI) | n | freq | P-value | OR (95%CI) | |
A/A | 561 | 0.575 | 556 | 0.560 | 3.4x10−4 | 1.8 (1.3–2.7) | 771 | 0.573 | 1.3x10−4 | 1.9 (1.3–2.7) | |
A/G | 337 | 0.345 | 391 | 0.394 | 515 | 0.383 | |||||
G/G | 78 | 0.080 | 45 | 0.045 | 59 | 0.044 |